pembrolizumab
merck
['pembro']
keynote -826 final overall survival results in cervical cancer treated with chemo/pembro/+\-bev; durable impressive os/pfs benefit #asco2023 
Gynecologic Oncologist at Rutgers Cancer Institute of New Jersey.        Clinical trials/ developmental therapeutics.